Illumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal Officer

Illumina appointed Michael Sullivan as Chief Commercial Officer, effective July 20, 2026, and Julie Coletti as Chief Legal Officer, effective August 3, 2026. Sullivan brings over 30 years of commercial leadership experience from firms including Caris Life Sciences, Roche Diagnostics, and Abbott Diagnostics. He will lead Illumina's global commercial organization. Coletti joins from Align Technology, where she served as Chief Legal and Regulatory Officer, bringing extensive legal and governance expertise from Danaher and Bayer HealthCare.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.